A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine

Get answers to your GYN Cancer questions.
Dr. Sarah Temkin’s Bio | Q&A Archive
Stromal tumor; Gonadal stromal tumor; Sex cord tumor; Androblastoma
Arrhenoblastoma of the ovary is an ovarian tumor that releases the male hormone, testosterone, or other hormones.
See also: Sertoli-Leydig cell tumor
This is a rare tumor. It accounts for less than 0.5% of all ovarian tumors.
These tumors are found in women of all age groups, but are most common in young women.
This tumor releases male hormones, which causes the following symptoms in women:
Surgery is the main treatment. If the cancer has spread, chemotherapy or radiation therapy should be considered.
You can ease the stress of illness by joining a support group where members share common experiences and problems. See cancer - support group.
The outcome of this disease depends on whether it has spread, and whether surgery can completely remove the tumor. The overall 5-year survival rate is 70 - 90%.
Arrhenoblastoma has a low chance of spreading. If the tumor is found early, the cure rate can be very good.
Call your health care provider if you are a woman experiencing masculine symptoms, or you feel a lump near your ovaries.
There is no good screening test. Getting a gynecological exam each year and recognizing masculine symptoms can help detect the disease.
Bulun SE, Adashi EY. The physiology and pathology of the female reproductive axis. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology. 11th ed. Philadelphia, Pa: Saunders Elsevier; 2008:chap 16.
Coleman RL, Gershenson DM. Neoplastic diseases of the ovary: screening, benign and malignant epithelial and germ cell neoplasms, sex-cord stromal tumors. In: Katz VL, Lentz GM, Lobo RA, Gershenson DM, eds. Comprehensive Gynecology. 5th ed. Philadelphia, Pa: Mosby Elsevier; 2007:chap 33.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885